Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baptiste Hervier

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Rheumatology (Oxford, England)|March 16, 2021
Treatment strategies and safety of rechallenge in the setting of immune checkpoint inhibitors-related myositis: a national multicentre studyAmandine Weill, Julie Delyon, Vincent Descamps, et al.
The Lancet. Rheumatology|January 26, 2024
Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trialOlivier Benveniste, Jean-Yves Hogrel, Lisa Belin, et al.
Rheumatology (Oxford, England)|October 29, 2014
Seronegative polyarthritis revealing antisynthetase syndrome: a multicentre study of 40 patientsGuillaume Lefèvre, Alain Meyer, David Launay, et al.
Journal of Autoimmunity|November 2, 2022
Efficacy of plasma exchange in patients with anti-MDA5 rapidly progressive interstitial lung diseasePierre Bay, Marc Pineton de Chambrun, Vincent Rothstein, et al.
Acta Neuropathologica|May 25, 2022
Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositisCorinna Preuße, Barbara Paesler, Christopher Nelke, et al.
Arthritis Research & Therapy|January 10, 2020
Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patientsAlain Meyer, Yves Troyanov, Julie Drouin, et al.
Eclinicalmedicine|June 6, 2024
Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)Francesco Pegoraro, Matthias Papo, Fleur Cohen-Aubart, et al.
Neurology|June 4, 2020
Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 casesYves Allenbach, Yurdagul Uzunhan, Ségolène Toquet, et al.
Journal of Internal Medicine|November 24, 2025
Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profileValentine Pagis, Quentin Astouati, Lucas Pacoureau, et al.
Arthritis Research & Therapy|November 13, 2025
Revisiting the link between oropharyngeal dysphagia and cancer in autoimmune myositis: a descriptive studyHao Cheng Shen, Océane Landon-Cardinal, Josiane Bourré-Tessier, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Rheumatology (Oxford, England)|March 16, 2021
Treatment strategies and safety of rechallenge in the setting of immune checkpoint inhibitors-related myositis: a national multicentre studyAmandine Weill, Julie Delyon, Vincent Descamps, et al.
The Lancet. Rheumatology|January 26, 2024
Sirolimus for treatment of patients with inclusion body myositis: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2b trialOlivier Benveniste, Jean-Yves Hogrel, Lisa Belin, et al.
Rheumatology (Oxford, England)|October 29, 2014
Seronegative polyarthritis revealing antisynthetase syndrome: a multicentre study of 40 patientsGuillaume Lefèvre, Alain Meyer, David Launay, et al.
Journal of Autoimmunity|November 2, 2022
Efficacy of plasma exchange in patients with anti-MDA5 rapidly progressive interstitial lung diseasePierre Bay, Marc Pineton de Chambrun, Vincent Rothstein, et al.
Acta Neuropathologica|May 25, 2022
Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositisCorinna Preuße, Barbara Paesler, Christopher Nelke, et al.
Arthritis Research & Therapy|January 10, 2020
Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patientsAlain Meyer, Yves Troyanov, Julie Drouin, et al.
Eclinicalmedicine|June 6, 2024
Long-term outcome and prognosis of mixed histiocytosis (Erdheim-Chester disease and Langerhans Cell Histiocytosis)Francesco Pegoraro, Matthias Papo, Fleur Cohen-Aubart, et al.
Neurology|June 4, 2020
Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 casesYves Allenbach, Yurdagul Uzunhan, Ségolène Toquet, et al.
Journal of Internal Medicine|November 24, 2025
Janus kinase and calcineurin-inhibitor combination in anti-MDA5 dermatomyositis: No significant survival benefit but reassuring safety profileValentine Pagis, Quentin Astouati, Lucas Pacoureau, et al.
Arthritis Research & Therapy|November 13, 2025
Revisiting the link between oropharyngeal dysphagia and cancer in autoimmune myositis: a descriptive studyHao Cheng Shen, Océane Landon-Cardinal, Josiane Bourré-Tessier, et al.
Pageof 8